Scholarlink

Hypoxic resistance of living tissue to cytotoxin, most notably radiation, has been known for over a century but was believed in early trials to be a universal characteristic of all tumors. Oxygen electrode measurements of tumor pO2 demonstrated that many tumors had insufficient hypoxia to affect tumor resistance. Electron paramagnetic resonance oxygen images have been shown to accurately quantify and locate tumor hypoxia. Using novel radiation delivery for preclinical models with isocentric tumor boosts using 3D printed radiation apertures, we compared tumor control after equivalent integral dose boosts—either to hypoxic tumor or to well-oxygenated tumor—in preclinical models. For the first time, in three preclinical tumor models, we demonstrated a significant advantage for hypoxic boosts relative to well-oxygenated boosts.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Letting Biology Validate the EPR Imaging of Tumor pO2

  • 会议论文

  • 发表日期：

    2026年

查看全文
  • Inna Gertsenshteyn,
  • Lucas Berens,
  • Boris Epel,
  • Eugene Barth,
  • Richard C. Miller,
  • Subramanian V. Sundramoorthy,
  • Mihai Giurcanu,
  • John Lukens,
  • Kayla Hall,
  • Viktor M. Tormyshev,
  • Bulent Aydogan,
  • Ralph R. Weichselbaum,
  • Mrignayani Kotecha,
  • Chin-Tu Chen,
  • Howard J. Halpern

摘要

Hypoxic resistance of living tissue to cytotoxin, most notably radiation, has been known for over a century but was believed in early trials to be a universal characteristic of all tumors. Oxygen electrode measurements of tumor pO2 demonstrated that many tumors had insufficient hypoxia to affect tumor resistance. Electron paramagnetic resonance oxygen images have been shown to accurately quantify and locate tumor hypoxia. Using novel radiation delivery for preclinical models with isocentric tumor boosts using 3D printed radiation apertures, we compared tumor control after equivalent integral dose boosts—either to hypoxic tumor or to well-oxygenated tumor—in preclinical models. For the first time, in three preclinical tumor models, we demonstrated a significant advantage for hypoxic boosts relative to well-oxygenated boosts.